Search results
...Economic Model Data for APHEXDA® (motixafortide) as part of CD34+ Hematopoietic Stem Cell...
WTNH-TV New Haven· 2 days ago...commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare...
Elrexfio and dosage: Strengths, form, when to use, and more
Medical News Today· 2 days agoElrexfio (elranatamab-bcmm) is a brand-name drug that’s prescribed for specific cases of multiple ...
Adaptive Biotechnologies Q1 2024 Earnings: Revenue Beats Estimates Amidst Challenges
GuruFocus.com via Yahoo Finance· 3 hours agoIts flagship product, clonoSEQ, is an FDA-authorized test used for detecting and monitoring minimal residual disease (MRD) in various cancers, including multiple ...
Velcade and cost: Reducing long-term drug costs and more
Medical News Today· 7 days agoVelcade (bortezomib) is a brand-name powder for injection that’s prescribed for multiple myeloma and...
Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoGenmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript May 2, 2024 Genmab A/S reports earnings...
Join Morehead City's first Battle of the Badges Blood Drive
News Channel 12 New Bern· 11 hours agoThe Morehead City Police and Fire-EMS departments are hosting their first 'Battle of the Badges' blood drive later this week. This event is scheduled to take place on Thursday, May 9 from 7: ...
Earnings call: GSK forecasts growth with strong Q1 performance
Investing.com· 4 days agoGSK (GSK) reported robust earnings for the first quarter, with a 13% increase in sales to £7.4...
C.J. Sansom, bestselling author of historical mysteries, dies at 71 | Texarkana Gazette
Texarkana Gazette· 7 days agoThe cause was multiple myeloma, said Maria Rejt, his publisher and editor at Mantle, an imprint of...
Xpovio dosage: Form(s), strength(s), how to use, and more
Medical News Today· 7 days agoGet the facts on Xpovio dosages. You can also learn how to take the drug, which form it comes in,...
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FOX 59 Indianapolis· 6 days agoKaryopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an aggregate of 72,700 restricted ...